Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00079053
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2004-03-08
Brief Title:
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Sponsor:
NCIC Clinical Trials Group
Organization:
Canadian Cancer Trials Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV salivary gland cancer | View |
| stage III squamous cell carcinoma of the hypopharynx | View |
| stage III squamous cell carcinoma of the larynx | View |
| stage III squamous cell carcinoma of the lip and oral cavity | View |
| stage III squamous cell carcinoma of the nasopharynx | View |
| stage III squamous cell carcinoma of the oropharynx | View |
| stage III squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| stage IV squamous cell carcinoma of the hypopharynx | View |
| stage IV squamous cell carcinoma of the larynx | View |
| stage IV squamous cell carcinoma of the lip and oral cavity | View |
| stage IV squamous cell carcinoma of the nasopharynx | View |
| stage IV squamous cell carcinoma of the oropharynx | View |
| stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| salivary gland squamous cell carcinoma | View |
| stage III salivary gland cancer | View |